Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Debt repayment
Repay or prepay borrowings of the company and its subsidiaries, AKS Medical and Research Centre and Ramraja Multispeciality Hospital.
Hospital capital expenditure
Fund capital expenditure for the Noida and Greater Noida hospitals.
Subsidiary capital expenditure
Fund capital expenditure requirements of subsidiaries.
Inorganic growth
Fund potential acquisitions and other inorganic growth opportunities.
General corporate purposes
Fund general corporate purposes of the company.
No lots distribution added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Yatharth Hospital and Trauma Care Services Limited is a Delhi NCR centric multi specialty hospital chain, incorporated in 2008. The company began operations with its first facility in Greater Noida in November 2010 and has since grown into one of the larger private hospital operators in the region. As of its IPO filing, the group operated four hospitals with a combined capacity of roughly 1,405 beds and around 370 doctors across specialties including cardiology, nephrology, neurosciences and orthopedics. Three of the hospitals are located in Noida, Greater Noida and Noida Extension in Uttar Pradesh, while a fourth was added in Orchha, Madhya Pradesh through an acquisition. The hospitals are equipped with advanced diagnostic and treatment infrastructure, including cardiac catheterization labs and MRI systems, and are NABH accredited, with two also holding NABL accreditation. The company is empanelled with a range of government and private healthcare schemes, which widens its addressable patient base. It has posted steady growth in revenue and profit over the years leading up to the IPO, supported by rising healthcare awareness and insurance penetration in India, both of which are expected to continue driving bed occupancy and patient volumes going forward.
Ahead of the issue opening, the company raised about Rs 206 crore from anchor investors at the cap price of Rs 300 per share. Participating anchor investors included ICICI Prudential, Nippon Life, HDFC Mutual Fund, Aditya Birla Sun Life, Bandhan Mutual Fund, HSBC Global Investment Funds, SBI Life Insurance, Goldman Sachs, Max Life Insurance and Kotak Mahindra Life, among others.
Source: RHP • Analysis provided for informational purposes
Last Updated: 18 July 2026, 5:30 AM
Consistent financial growth
Revenue and profit grew steadily across the three years before the IPO, reflecting an expanding patient base and operating scale.
Quality accreditation
All its hospitals hold NABH accreditation, with two also NABL accredited, supporting trust with patients, doctors and insurers.
Broad payer network
The company is empanelled with numerous government and private healthcare schemes, widening its addressable patient base.
Favorable demand trends
Rising health insurance penetration and healthcare awareness in India are expected to support higher bed occupancy in the years ahead.
Underperforming facility
A large share of the fresh issue proceeds funds the Jhansi-Orchha hospital, which was shut for about two years and posted losses even after reopening.
Key-person dependence
The business relies heavily on its promoters and senior management, and losing them could hurt operations.
COVID-linked revenue decline
A meaningful share of past revenue came from COVID-19 related treatment, income that is unlikely to repeat.
MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.
Competitive pressure
The company competes with other hospital chains and healthcare providers across its regions of operation.